What is the Purpose of this Study?
Primary Objective 1. The overall objective of the study is to evaluate the clinical efficacy of different investigational therapeutics relative to the control arm in patients hospitalized with COVID-19. The primary objective will be determined by a pilot study of the first 100 subjects. Subject clinical status (7-point ordinal scale) at Day 15 is the default primary endpoint.
Eligibility
- 1. Admitted to a hospital with symptoms suggestive of COVID-19 infection.
- 2. Subject (or legally authorized representative) provides informed consent prior to initiation of any study procedures.
- 3. Subject (or legally authorized representative) understands and agrees to comply with planned study procedures.
- 4. Male or non-pregnant female adult \> / = 18 years of age at time of enrollment.
Where can I participate?
Beverly
More about this Clinical Trial
What is the full name of this clinical trial?
A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults